Kataoka T, Oh-hashi F, Sakurai Y, Ida N
Cancer Chemother Pharmacol. 1982;9(2):75-80. doi: 10.1007/BF00265382.
We compared the in vitro antiproliferative activity of highly purified interferon (IFN)-beta (greater than 10(7) U protein/mg in antiviral activity) with that of IFNs-alpha and lymphoblastoid, using human cells of malignant and non-malignant origin. IFN-beta was the least active of three IFNs in suppressing Daudi cell proliferation. Three hematological cells other than Daudi cells cultivated in suspension were insensitive to each of three IFNs. IFN-beta was more active than IFNs-alpha and lymphoblastoid in suppressing all eight epithelioid cells tested and, particularly with respect to five epithelioid cells sensitive to IFN, IFN-beta was seven to 49 times as active as IFN-alpha. These results indicate that suppression of cell proliferation by IFN depends not only on the target cell species but also on the IFN species, and emphasize the need for careful selection of the most appropriate IFN species in therapy. We found that the antiproliferative characteristics of the present IFN-beta preparation were consistent with those reported previously, supporting the idea that IFN-beta molecules in the present preparation were responsible for suppressing cell proliferation. The antiproliferation activity of our preparation was species-specific but not selective for cells of malignant origin; it was absorbable by IFN-sensitive but not by IFN-insensitive cells; and it was achieved by a cytostatic effect.
我们使用恶性和非恶性来源的人类细胞,比较了高度纯化的β干扰素(体外抗病毒活性大于10⁷U蛋白/毫克)与α干扰素及淋巴母细胞样干扰素的体外抗增殖活性。在抑制Daudi细胞增殖方面,β干扰素是三种干扰素中活性最低的。除悬浮培养的Daudi细胞外,另外三种血液学细胞对三种干扰素均不敏感。在抑制所有八种测试的上皮样细胞方面,β干扰素比α干扰素和淋巴母细胞样干扰素更具活性,特别是对于五种对干扰素敏感的上皮样细胞,β干扰素的活性是α干扰素的7至49倍。这些结果表明,干扰素对细胞增殖的抑制不仅取决于靶细胞种类,还取决于干扰素种类,并强调在治疗中需要谨慎选择最合适的干扰素种类。我们发现,目前制备的β干扰素的抗增殖特性与先前报道的一致,支持了目前制剂中的β干扰素分子负责抑制细胞增殖的观点。我们制剂的抗增殖活性具有物种特异性,但并非对恶性来源的细胞具有选择性;它可被对干扰素敏感的细胞吸收,但不能被对干扰素不敏感的细胞吸收;并且它是通过细胞抑制作用实现的。